Cancer Research Technology
Log in Register
Menu

phOC-iNOS Vector

Invented by Dr Helen McCarthy at Queen's University Belfast

Info

Catalogue Number 153288
Bacterial Resistance Kanamycin
Vector Type pcDNA 3.1
Synonyms Nitric Oxide Synthase
Antigen/Gene or Protein Targets Inducible Nitric Oxide Synthase
Relevance phOC-iNOS Plasmid is a human nitric oxide synthase (iNOS) transgene driven by a human osteocalcin (hOC) promoter to control inducible nitric oxide synthase (iNOS) transgene expression in hormone refractory prostate cancer (HRPC). The plasmid was originally developed as an anti-cancer therapeutic with a view to a gene therapy strategies. Studies in the literature have demonstrated that this plasmid increases iNOS protein and total nitrite levels in PC3 and DU145 cells, but not LNCaP or
HT29 (McCarthy et al., 2007). The plasmid serves as a useful tool in cardiovascular studies or any physiology associated with vasodilation.
Research Area Cancer, Metabolism, Neurobiology
Notes Recommended for transpormation in DH5 alpha bacterial cells
iNOS gene is 4.4kb

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

McCarthy et al. 2007. J Gene Med. 9(6):511-20. PMID: 17471586.

Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.

Europe PMC ID: 17471586


Add a reference

References: 2 entries

McCarthy et al. 2007. J Gene Med. 9(6):511-20. PMID: 17471586.

Human osteocalcin: a strong promoter for nitric oxide synthase gene therapy, with specificity for hormone refractory prostate cancer.


Add a reference